Patents by Inventor Daniel Gliddon

Daniel Gliddon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSAGE REGIMES FOR THE ADMINISTRATION OF A LAG-3/PD-L1 BISPECIFIC ANTIBODY
    Publication number: 20220275092
    Abstract: The application relates to dosage regimes for the administration of an antibody molecule which binds programmed death-ligand 1 (PD-L1) and lymphocyte-activation gene 3 (LAG-3) and their medical use in the treatment of cancer in human patients.
    Type: Application
    Filed: May 14, 2020
    Publication date: September 1, 2022
    Applicant: F-star Therapeutics Limited
    Inventors: Michelle Morrow, Fiona Germaschewski, Daniel Gliddon, Kin-mei Leung, Cristian Gradinaru, Christopher Shepherd, Josefin-Beate Holz, Louis Kayitalire